Immunological Diseases

27
Navid Jubaer Lecturer The University of Asia Pacific IMMUNOLOGICAL DISORDERS 1

Transcript of Immunological Diseases

Page 1: Immunological Diseases

Navid JubaerLecturer

The University of Asia Pacific

IMMUNOLOGICAL DISORDERS

1

Page 2: Immunological Diseases

2

An immune disorder is a dysfunction of the immune system. These disorders can be characterized in several different ways:

• By the component(s) of the immune system affected

• By whether the immune system is overactive or underactive

• By whether the condition is congenital or acquired

IMMUNOLOGICAL DISORDER

Page 3: Immunological Diseases

3

Definition:

A state of altered reactivity in which the body reacts with an exaggerated immune response to what is perceived as a foreign substance.

Immune response that results in tissue injury or other physiological changes are called hypersensitivity (allergic) reactions”. 

HYPERSENSITIVITY (ALLERGY)

Page 4: Immunological Diseases

4

Hypersensitivity reactions are classified into four types:

• Type I: Anaphylactic hypersensitivity

• Type II: Cytotoxic hypersensitivity

• Type III: Immune complex hypersensitivity

• Type IV: Cell mediated hypersensitivity

TYPES OF HYPERSENSITIVITY REACTIONS

Page 5: Immunological Diseases

5

• It is an immediate reaction beginning within minutes of exposure to an antigen.

• It is mediated by antibodies.

• It requires previous exposure to specific antigen.

• It usually affects on skin, lungs and gastrointestinal tract.

• Examples:– Asthma– Allergic rhinitis– Systemic anaphylaxis.– Atopic dermatitis

TYPE I: ANAPHYLACTIC HYPERSENSITIVITY:

Page 6: Immunological Diseases

6

Anaphylactic (type I) Hypersensitivity

Page 7: Immunological Diseases

7

• It occurs when the system mistakenly identifies a normal constituent of the body as foreign.

• This reaction may be a result of cross-reacting antibody, possibly leading to cell and tissue damage

• It involves activation of complement by IgG or IgM antibody binding to an antigenic cell.

Examples:

• Myasthenia gravis

• Thrombocytopenia

TYPE II: CYTOTOXIC HYPERSENSITIVITY

Page 8: Immunological Diseases

Pathogenesis of type II hypersensitivity8

Cytotoxic (type Il) Hypersensitivity

Page 9: Immunological Diseases

9

• It involves in the formation of immune complexes when antigen binds to antibodies.

• These type III complexes deposit in tissues or vascular endothelium and leads to injury with the help of vasoactive amines and the increase number of circulating complexes.

• The joints and kidneys are particularly susceptible.

Examples:

• Systemic lupus erythematous

• Rheumatoid arthritis

• Serum sickness

TYPE III: IMMUNE COMPLEX HYPERSENSITIVITY

Page 10: Immunological Diseases

10

IMMUNE COMPLEX (TYPE III) HYPERSENSITIVITY

Pathogenesis of type III hypersensitivity

Page 11: Immunological Diseases

11

• Also known as cellular hypersensitivity

• It occurs 24-72 hrs after exposure to an allergen

• The reaction is mediated by sensitized T cells and macrophages.

• The reaction results In tissue damage by releasing lymphokines, macrophages and lysozymes.

Examples:

• Contact dermatitis

• Tuberculin test.

TYPE IV: CELL MEDIATED HYPERSENSITIVITY

Page 12: Immunological Diseases

12

CELL MEDIATED (TYPE IV) HYPERSENSITIVITY

Pathogenesis of type IV hypersensitivity

Page 13: Immunological Diseases

13

It is also called as Hay FeverDefinition: It is an inflammation of the nasal mucosa by an allergen.

ALLERGIC RHINITIS

Page 14: Immunological Diseases

PATHOGENESIS: ALLERGIC RHINITIS

14

Inhalation of an antigen (sensitization)

Re-exposure

Nasal mucosa reacts (histamine is mediator)

Slowing of ciliary action, edema formation and leukocyte infiltration

Tissue edema and increase capillary permeability (vasodilatation).

Page 15: Immunological Diseases

15

Clinical manifestations:• Nasal congestion• Clear to greenish rhinorrhea• Intermittent sneezing and nasal itching• Headache • Epistaxis• Fatigue, loss of sleep and poor coordination.

Medical management:• Oral anti histamines (blocks the action of histamine)• Nasal decongestant• Mast cell stabilizers.• Analgesics and antipyretics.

Page 16: Immunological Diseases

ATOPIC DERMATITIS (ECZEMA)

16

Definition:Inflammation of the skin

Incidences/Causes:• Familial tendency

• It is highest in infants and children

• 1% population is suffering from this disease

• Aggravated in low humidity and in winter.

Page 17: Immunological Diseases

PATHOPHYSIOLOGY: ATOPIC DERMATITIS

17

Allergen /Sensitizing antigen

Affect the skin (changes in lipid content, sebaceous gland activity and sweating)

Reduced water-binding capacity of the skin

Higher trans epidermal water loss and decreased water content

Dry skin

Itching, rubbing leads to infection

Page 18: Immunological Diseases

18

Clinical manifestations: Atopic dermatitis

• Red oozing crusting rash (in childhood)• Dry thick brownish – grey and scaly skin (later

stage)• Pruritus• Lesion are mostly found on hand, foot, back of

the knees, neck, face, eyelids and elbow bands.

Medical Management: Atopic dermatitis • Moisturizers• Antibiotics• Antihistamines

Page 19: Immunological Diseases

19

AnaphylaxisDefinition:It is an immediate life threatening systemic reaction that can occur on exposure to particular substances

It is an immediate (type I hypersensitivity) immunologic reaction, results from IgE antibody

This reaction affects many tissues and organs. Death may occur due to respiratory tract spasm and constriction or collapse.

Causes

• Food ( peanuts, fish, milk, eggs, wheat and chocolate).

• Medications (penicillin, NSAID’s)

• Insects stings (bees, ants)

Page 20: Immunological Diseases

20

Pathophysiology: Anaphylaxis

Interaction of foreign antigen with IgE antibodies

Release of histamine

Activation of platelets, eosinophils and neutrophils

smooth muscle spasm, bronchospasm, mucosal edema and inflammation.

Page 21: Immunological Diseases

Mild Moderate Severe

Occurs within first 2hrs of exposure

Same Same

Peripheral tingling Flushing Bronchospasm

Sensation of warmth

Itching Laryngeal edema

Fullness in mouth and throat

Bronchospasm Severe Dyspnea, cyanosis

Nasal congestion Edema of larynx Hypotension

Periorbital swelling

Dyspnea Cardiac arrest and coma may follow.

Pruiritus Cough  

Sneezing wheezing  

21

Clinical manifestations: Anaphylaxis

Page 22: Immunological Diseases

22

Medical management: Anaphylaxis

1. If cardiac arrest then cardiopulmonary resuscitation initiated.

2. Antihistamine to prevent recurrence reaction3. Start intravenous fluids to maintain hemodynamics.4. Give aminophylline for bronchospasm

Page 23: Immunological Diseases

23

• Transplant rejection occurs when transplanted tissue is rejected by the recipient's immune system, which destroys the transplanted tissue.

• Transplantation can be:

autologous (own)

homologous (alogenic) - human tissue

heterologous - animal tissue (pig skin, ovine pericardium)

TRANSPLANTATION REJECTION

Page 24: Immunological Diseases

24

• hyperacute (Ab mediated) - widespread arteriolitis, arteritis, ischemic necrosis (minutes-hours)

• acute (cell mediated) - vasculitis, tubulitis, edema (days-months)

• chronic - vascular changes - sclerosis, intimal fibrosis (months-years)

REJECTION REACTIONS

Page 25: Immunological Diseases

25

• GVHD happens when particular types of white blood cell (T cells) in the donated bone marrow or stem cells attack host body cells. This happens because the donated cells (the graft) see the body cells (the host) as foreign and attack them.

• It is difficult to say who will develop GVHD after a transplant. We don’t know exactly, but somewhere between 1 and 4 out of every 5 people (20 to 80%) having a donor transplant will develop some degree of GVHD. Some people have a very mild form which doesn’t last long. For others, GVHD can be severe. It may even be life threatening in a few cases. Some people may have GVHD over many months, or even years.

GRAFT VERSUS HOST DISEASE

Page 26: Immunological Diseases

26

• GVHD happens because the transplant affects your immune system. The donor's bone marrow or stem cells will contain some T cells. T cells are a type of white blood cell that help us fight infections. T cells attack and destroy cells they see as foreign, and potentially harmful, such as bacteria and viruses. Normally T cells don’t attack our own body cells, because they recognize proteins on the cells called HLA (human leukocyte antigens). We inherit our HLA from our parents. Apart from identical twins HLA is unique to each person.

• Before a bone marrow or stem cell transplant, you and your donor have blood tests to check how closely your HLA matches. This test is called tissue typing. If you and your donor have very similar HLA this lowers the chance of GVHD. The more differences there are between your HLA and your donor's, the more likely you are to get GVHD.

• After a transplant your bone marrow starts making new blood cells from the donor stem cells. These new blood cells have the donor's HLA pattern. They recognize the HLA pattern on your body cells as different (foreign) and may begin to attack some of them. The GVHD may affect different areas of your body. Most commonly it affects the

• Skin

• Digestive system (including the bowel and stomach)

• Liver

HOW GVHD DEVELOPS

Page 27: Immunological Diseases

27

THANK YOU